Fiduciary Wealth Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Fiduciary Wealth Partners's LLY Position: Q1 2026 in Review
Fiduciary Wealth Partners sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 324 shares — an estimated $348K sold.
Fiduciary Wealth Partners first reported a position in LLY in Q1 2025 and held it in 4 quarters. The position peaked at $348K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Fiduciary Wealth Partners reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
- Fiduciary Wealth Partners sold 324 Eli Lilly shares in Q1 2026, an estimated $348K.
- Fiduciary Wealth Partners first reported a position in Eli Lilly in Q1 2025 and held it in 4 quarters.
- Fiduciary Wealth Partners's Eli Lilly position peaked at $348K in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Fiduciary Wealth Partners's 13F filing for Q1 2026, filed 7 May 2026.